Abstract: According to this invention there is provided a herbal formulation for the prevention and management of neurodegenerative disorders comprising, hydro-methanolic extract of at least one plant selected from Curcuma longa, Bacopa monnieri and Valeriana jatamansi, at 70-80° C., maintaining the pH of the solution between 7-10, Separating the active compounds chromatographically and Subjecting the active compounds to the step of molecular characterization.

Abstract: The invention relates to a plant based formulation for the prevention and management of Metabolic Syndrome and Cardiovascular disease mortality risk comprising an effective amount of a hydro-alcoholic extract of Salacia parviflora, Tribulus terrestris and Dioscorea glabra.

Abstract: The invention relates to a plant based formulation for the prevention and management of Irritable Bowel Syndrome (IBS) comprising of effective amount of a hydro-alcoholic extract of Acacia arabica, Aegle marmelos and Nardostachys jatamansi.

Abstract: The invention relates to a plant based formulation for the prevention and management of obesity and associated complications comprising of an effective amount of hydro-alcoholic extract of Salacia reticulata, Garcinia indica, Dioscorea bulbifera, Terminalia chebula and optionally additives in trace amounts.

Abstract: The invention relates to a plant based formulation for the prevention and management of Irritable Bowel Syndrome (IBS) comprising of effective amount of a hydro-alcoholic extract of Acacia arabica, Aegle marmelos and Nardostachys jatamansi.

Abstract: The invention relates to a plant based formulation for the prevention and management of Metabolic Syndrome and Cardiovascular disease mortality risk comprising an effective amount of a hydro-alcoholic extract of Salacia parviflora, Tribulus terrestris and Dioscorea glabra.

Abstract: According to this invention there a novel herbal formulation for the prevention and management of coronary heart disease and associated CHD risk factors, comprising, preparing a hydromethanolic extract of at least two plants selected from of Withania somnifera, Costus speciosus, Hippophae rhamnoides and Terminalia arjuna at 60-80° C., maintaining the pH of the solution between 7-10, separating the active compounds chromatographically, subjecting the active compounds to the step of molecular characterization.

Abstract: This invention relates to a novel herbal formulation for the prevention and management of type-2 diabetes mellitus and vascular complications associated with diabetes comprising, preparing of hydromethanolic extract of at least one plant selected form Salacia roxburghii, Salacia oblonga, Garcinia Indica and Lagerstroemia parviflora at 70°-80° C., maintaining ph of the solution between 7-10, separating the active compounds by using TLC, HPLC, HPTLC, subjecting the active compounds to the step of molecular characterization.

Abstract: This invention relates to a novel herbal formulation for the prevention and management of type-2 diabetes mellitus and vascular complications associated with diabetes comprising, preparing of hydromethanolic extract of at least one plant selected form Salacia roxburghii, Salacia oblonga, Garcinia Indica and Lagerstroemia parviflora at 70°-80° C., maintaining ph of the solution between 7-10, separating the active compounds by using TLC, HPLC, HPTLC, subjecting the active compounds to the step of molecular characterization.

Abstract: Pharmaceutical formulations comprising multiple drugs, for treating or preventing cardiovascular disease. Embodiments are capsules containing individual drugs, or combinations of drugs, in the form of small tablets.

Abstract: According to this invention there is provided a herbal formulation for the prevention and management of neurodegenerative disorders comprising, hydro-methanolic extract of at least one plant selected from Curcuma longa, Bacopa monnieri and Valeriana jatamansi, at 70-80° C., maintaining the pH of the solution between 7-10, Separating the active compounds chromatographically and Subjecting the active compounds to the step of molecular characterization.

Abstract: According to this invention there a novel herbal formulation for the prevention and management of coronary heart disease and associated CHD risk factors, comprising, preparing a hydromethanolic extract of at least two plants selected from of Withania somnifera, Costus speciosus, Hippophae rhamnoides and Terminalia arjuna at 60-80° C., maintaining the pH of the solution between 7-10, separating the active compounds chromatographically, subjecting the active compounds to the step of molecular characterization.

Abstract: Disclosed are processes for the production of fluorinated olefins, preferably adapted to commercialization of CF3CF?CH2 (1234yf). Three steps may be used in preferred embodiments in which a feedstock such as CCl2?CClCH2Cl (which may be purchased or synthesized from 1,2,3-trichloropropane) is fluorinated (preferably with HF in gas-phase in the presence of a catalyst) to synthesize a compound such as CF3CCl?CH2, preferably in a 80-96% selectivity. The CF3CCl?CH2 is preferably converted to CF3CFClCH3 (244-isomer) using a SbCl5 as the catalyst which is then transformed selectively to 1234yf, preferably in a gas-phase catalytic reaction using activated carbon as the catalyst. For the first step, a mixture of Cr2O3 and FeCl3/C is preferably used as the catalyst to achieve high selectivity to CF3CCl?CH2 (96%). In the second step, SbCl5/C is preferably used as the selective catalyst for transforming 1233xf to 244-isomer, CF3CFClCH3.

Abstract: Disclosed is a method for producing fluorinated organic compounds, including hydrofluoropropenes, which preferably comprises converting at least one compound of formula (I): CF3CFnCHmXa-m ??(I) to at least one compound of formula (II) CF3CZCHZ ??(II). where each X is independently Cl, F, I or Br; each Z is independently H or F; n is 1 or 2; m is 1, 2 or 3, provided that when n is 1, mis 1 or 2; a is 2 or 3, and a-m?0. Certain embodiments include the step of reacting fluorinated C2 olefin, such as tetrafluoroethylene, with a Cl addition agent under conditions effective to produce a compound of formula (I).

Abstract: Disclosed are methods for producing fluorinated organic compounds, including hydrofluoropropenes, which preferably comprises converting at least one compound of formula (I): CF3CHXCH2X ??(I) to at least one compound of formula (II) CF3CZCHZ ??(II). where X is independently Cl, Br, I or F, and Z independently is H or F. In certain preferred embodiments, each Z is different.

Abstract: A method for preparing fluorinated organic compounds comprising contacting hydrogen fluoride with at least one compound of formula I: CX3CXYCH3??I where each X is independently Cl, I or Br, and each Y is independently H or F, said contacting step being carried out under conditions effective to produce a compound of formula II CF3CZCH2??II where Z is Cl, I, Br, or F.